Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Interest & Investment Income: 2019-2025

Historic Interest & Investment Income for Eton Pharmaceuticals (ETON) over the last 4 years, with Sep 2025 value amounting to -$592,000.

  • Eton Pharmaceuticals' Interest & Investment Income fell 7300.00% to -$592,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year decrease of 2519.61%. This contributed to the annual value of $281,000 for FY2019, which is 71.34% up from last year.
  • Per Eton Pharmaceuticals' latest filing, its Interest & Investment Income stood at -$592,000 for Q3 2025, which was up 43.30% from -$1.0 million recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year Interest & Investment Income high stood at -$8,000 for Q3 2024, and its period low was -$1.0 million during Q2 2025.
  • For the 3-year period, Eton Pharmaceuticals' Interest & Investment Income averaged around -$335,111, with its median value being -$124,000 (2023).
  • Its Interest & Investment Income has fluctuated over the past 5 years, first skyrocketed by 91.27% in 2024, then slumped by 9,245.45% in 2025.
  • Eton Pharmaceuticals' Interest & Investment Income (Quarterly) stood at -$31,000 in 2023, then skyrocketed by 74.19% to -$8,000 in 2024, then slumped by 7,300.00% to -$592,000 in 2025.
  • Its Interest & Investment Income was -$592,000 in Q3 2025, compared to -$1.0 million in Q2 2025 and -$1.0 million in Q1 2025.